订阅小程序
旧版功能

Abstract #22: Impact of Somatic TP53 Mutation Type on Benefit from Bevacizumab in Patients with Ovarian Cancer, a Secondary Analysis of NRG/GOG-0218

Gynecologic Oncology Reports(2024)

引用 0|浏览1
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要